Effect of mutagen-induced cell lethality on the dose response of germline mutations

W R Lee1, D C Perantie, K B Clark

  • 1Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA. leemuta@lsu.edu

Insights

Molecular tests for mutations can be biased by stem cell death. This study compares conventional and molecular analysis methods using Drosophila melanogaster sex-linked recessive lethal tests to improve accuracy for mutation detection.

Area of Science:

  • Genetics
  • Molecular Biology
  • Toxicology

Background:

  • Molecular tests for mutations require DNA extraction from tissue samples.
  • In vivo mutation tests face challenges like stem cell lethality, which can bias results.
  • Compensatory mechanisms in surviving stem cells can mask the true impact of mutagens.

Purpose of the Study:

  • To compare conventional analysis of sex-linked recessive lethal (SLRL) data with a simulated molecular analysis.
  • To identify potential biases in mutation detection when comparing in vivo and molecular testing methods.
  • To propose a method for correcting biases in molecular mutation detection.

Main Methods:

  • Utilized the sex-linked recessive lethal (SLRL) test in Drosophila melanogaster as a model system.
  • Exposed spermatogonia cells in male larvae to N-ethyl-N-nitrosourea (ENU).
  • Analyzed SLRL data using two methods: conventional counting of all mutations and simulated molecular analysis with equal progeny samples per male.

Main Results:

  • Conventional analysis counts each mutation within a cluster, potentially overestimating mutation frequency.
  • Simulated molecular analysis requires a correction factor to account for changes in mutation cluster size.
  • Stem cell lethality introduces a downward bias in mutation detection, particularly at higher mutagen doses.

Conclusions:

  • Molecular mutation tests can be subject to downward bias due to stem cell lethality.
  • A correction factor is necessary when adapting in vivo mutation data for molecular analysis.
  • This research highlights the importance of accounting for biological complexities in mutation detection assays.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Mutations01:39

Mutations

Overview
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...